Oximetry reveals abnormal oxygen metabolism in exudative AMD

Article

Professor Stef?nsson reveals the results of a comparative study demonstrating that observation of metabolic processes is possible enabling insight into the pathophysiology of disease.

The design of the non-invasive retinal oximeter is based on a fundus camera. It simultaneously captures images of the retina at 600 nm and 570 nm and estimates retinal vessel oxygen saturation, then producing an image in which the degrees of oxygen saturation are indicated by different colours.

To establish whether the retina metabolises oxygen differently in an eye with AMD than in a healthy eye, the Oximetry Group in Reykjavik, including Asbjorg Geirsdottir, Sveinn Hakon Hardarson and professor Einar Stefánsson (University of Iceland, National University Hospital, Reykjavik, Iceland) compared the oximetry images of healthy eyes with those of eyes with exudative AMD.

When oxygen saturation in AMD patients is compared with healthy individuals a statistically significant difference is seen. While the venous oxygen saturation of healthy individuals decreases with age, in AMD patients the opposite pattern is seen.

He continued, "The preliminary results indicate that oxygen metabolism is different in healthy and AMD eyes."

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
At EURETINA 2024, Martin S. Zinkernagel, MD, PhD, on the future of real-world AI use
Alexandra Miere, MD, PhD, Associate Professor of Ophthalmology, University Paris Est Créteil, France, speaks at EURETINA
Veeral S. Sheth, MD, MBA, FASRS, FACS, discussed the outcome of the Phase 1 HELIOS trial of OTX-TKI at from this year's EURETINA congress being held in Barcelona, Spain, which takes place September 19-22, 2024.
© 2024 MJH Life Sciences

All rights reserved.